The World Health Organization (WHO) has recommended Paxlovid, the antiviral medicine produced by Pfizer, for patients with COVID-19 at high risk of developing severe disease – but it is concerned about limited access to the life-saving medicine. Friday’s WHO recommendation is aimed at “patients with non-severe COVID-19 who are at highest risk of developing severe […] Continue reading ->
Getting medical supplies and equipment to those Ukrainians who need it as fighting intensifies is one of the World Health Organization’s (WHO) biggest concerns, according to WHO Europe spokesperson, Bhanu Bhatnagar on Tuesday. “An increase in fighting could further threaten our supply chains in and out of affected areas.,” said Bhatnagar, who is currently in […] Continue reading ->
Nathalie Strub-Wourgaft, a senior scientist at the Drugs for Neglected Disease Initiative (DNDi) has a vision that could be critical to halting the next pandemic – but is esoteric, difficult to organize and even more challenging to build the trust and buy-in needed to make it really work.  The vision is of a common clinical-trial […] Continue reading ->
Pharmaceutical giants have questioned why a waiver on intellectual property (IP) rights for COVID-19 vaccines is still on the table when they are battling to find markets for their vaccines amid order cancellations – including from the Africa Centre for Disease Control.  “I’m stunned that the proposed IP waiver is still being debated while supplies […] Continue reading ->
After years of being the neglected stepchild of global health, non-communicable diseases (NCDs) might finally be getting the urgent attention they need with Tuesday’s launch of an international NCD compact and presidential group. The measures were announced at the International Strategic Dialogue on NCDs and Sustainable Development Goals (SDGs) co-hosted by the governments of Ghana […] Continue reading ->